<?xml version="1.0" encoding="UTF-8"?>
<p>Transgender women experience a disproportionate burden of HIV. The most recent global meta-analysis of HIV among transgender women examined laboratory-confirmed HIV data from 15 countries over the period of 2001–2011. The pooled HIV prevalence for transgender women was 19%, with this group having a 49-fold higher odds of infection compared with other reproductive age adults [
 <xref rid="pmed.1002422.ref014" ref-type="bibr">14</xref>]. However, data were only available from countries with male-predominant epidemics, and no data were available from sub-Saharan Africa. A systematic review of the global HIV epidemiology among transgender populations was published in 2016, including research published between 2012 and 2015 [
 <xref rid="pmed.1002422.ref012" ref-type="bibr">12</xref>]. Although data were available from more than 30 studies around the world, none were from sub-Saharan Africa. Of the 20 countries that reported HIV prevalence data on transgender people to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2016, only 1, Democratic Republic of the Congo (DRC), was in sub-Saharan Africa [
 <xref rid="pmed.1002422.ref015" ref-type="bibr">15</xref>]. DRC reported HIV prevalence of 7.9% among transgender people compared with 0.7% among adults 15–49 years old and 3.3% among MSM [
 <xref rid="pmed.1002422.ref016" ref-type="bibr">16</xref>].
</p>
